THE ULTIMATE GUIDE TO AI IN CELL AND GENE THERAPY MARKET BY TECHNOLOGY, BY INDICATION, BY APPLICATION, BY END-USER (BIOPHARMACEUTICAL COMPANIES, RESEARCH INSTITUTES, HEALTHCARE PROVIDERS) AND BY REGION

Europe AI in healthcare market is anticipated to witness substantial advancement. This may be attributed to the common adoption of AI technologies and expanding investments in AI by the two federal government and personal businesses. When an organization has proven a substantial-degree gen AI tactic plus a blueprint for implementation, it will nee